Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
123M
-
Number of holders
-
129
-
Total shares
-
85.9M
-
Shares change
-
+6.2M
-
Total reported value, excl. options
-
$1.09B
-
Value change
-
+$76.3M
-
Put/Call ratio
-
1.26
-
Number of buys
-
78
-
Number of sells
-
-43
-
Price
-
$12.70
Significant Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q1 2014
143 filings reported holding HALO - HALOZYME THERAPEUTICS, INC. - Common Stock as of Q1 2014.
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85.9M shares
of 123M outstanding shares and own 69.66% of the company stock.
Largest 10 shareholders include Third Security, LLC (19.8M shares), VANGUARD GROUP INC (6.15M shares), BAKER BROS. ADVISORS LP (5.7M shares), BB BIOTECH AG (5.64M shares), Sectoral Asset Management Inc (5.36M shares), FMR LLC (5.28M shares), QVT Financial LP (4.22M shares), BlackRock Fund Advisors (3.96M shares), FRANKLIN RESOURCES INC (3.32M shares), and IRIDIAN ASSET MANAGEMENT LLC/CT (3.23M shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.